The Swedish Essential Tremor (SWEET) Trial
Key facts
- Where
- Gothenburg, Linköping, Lund, Stockholm, Umeå, and Uppsala, SwedenSee the 6 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT03832712, who can take part
Where in Sweden
- Sahlgrenska University HospitalGothenburg, SwedenContact: Thomas Skoglund, PhDNot yet recruiting
- Linkoping University HospitalLinköping, SwedenContact: Peter Zsigmond, PhDTaking people
- Lund University HospitalLund, SwedenContact: Hjalmar Bjartmarz, MDTaking people
- Karolinska University HospitalStockholm, SwedenContact: Anders Fytagoridis, PhDTaking people
- Umeå University HospitalUmeå, SwedenContact: Patric Blomstedt, PhDTaking people
- Akademiska sjukhusetUppsala, SwedenContact: Elena Jiltsova, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Karolinska Institutet
- Trial code
- NCT03832712
- Record updated
- 25 May 2022
- Original description
To evaluate the effect of deep brain stimulation (DBS) vs best medical treatment in essential tremor (ET) in a randomized, single-blinded controlled trial.Read full original descriptionShow less
The Swedish Essential Tremor (SWEET) Trial - A Multicentre Randomized Controlled Trial of Deep Brain Stimulation for Essential Tremor
To evaluate the effect of deep brain stimulation (DBS) vs best medical treatment in essential tremor (ET) in a randomized, single-blinded controlled trial.
Inclusion: Diagnosis of ET, as decided by the movement disorder specialist; Substantial incapacity; Duration of symptoms > 5 years; Age 18 - 75; unsatisfying effect from β-blockers, or be unable to tolerate the medical therapy.
Exclusion: Cognitive impairment; Co-morbidity or non-compliance likely to jeopardize the result or to confuse the evaluation; Normal surgical exclusion criteria.